tiprankstipranks
Trending News
More News >
Standard Biotools Inc (LAB)
NASDAQ:LAB
US Market

Standard BioTools (LAB) Financial Statements

Compare
468 Followers

Standard BioTools Financial Overview

Standard BioTools's market cap is currently $611.46M. The company's EPS TTM is $-0.09; its P/E ratio is ―; Standard BioTools is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 174.43M$ 106.34M$ 97.95M$ 130.58M$ 138.14M
Gross Profit$ 84.26M$ 50.45M$ 37.05M$ 69.37M$ 83.33M
Operating Income$ -175.24M$ -76.60M$ -116.20M$ -67.46M$ -51.04M
EBITDA$ -118.14M$ -54.46M$ -173.57M$ -44.27M$ -34.60M
Net Income$ -138.88M$ -74.66M$ -190.10M$ -59.24M$ -53.02M
Balance Sheet
Cash & Short-Term Investments$ 292.87M$ 114.89M$ 165.78M$ 28.45M$ 68.52M
Total Assets$ 612.34M$ 323.07M$ 390.31M$ 275.21M$ 324.76M
Total Debt$ 33.00M$ 98.21M$ 102.66M$ 111.65M$ 95.38M
Net Debt$ -133.73M$ 46.51M$ 21.35M$ 83.20M$ 26.86M
Total Liabilities$ 140.62M$ 471.12M$ 471.78M$ 180.62M$ 185.71M
Stockholders' Equity$ 471.72M$ -148.05M$ -81.47M$ 94.60M$ 139.05M
Cash Flow
Free Cash Flow$ -151.81M$ -46.12M$ -93.19M$ -57.33M$ -28.13M
Operating Cash Flow$ -143.45M$ -43.29M$ -89.37M$ -44.06M$ -15.42M
Investing Cash Flow$ 363.17M$ 20.24M$ -88.13M$ -11.95M$ 39.98M
Financing Cash Flow$ -102.62M$ -6.81M$ 230.76M$ 15.96M$ 20.86M
Currency in USD

Standard BioTools Earnings and Revenue History

Standard BioTools Debt to Assets

Standard BioTools Cash Flow

Standard BioTools Forecast EPS vs Actual EPS